Pharma Industry News Advanced Accelerator Applications receives FDA approval for Lutathera® for treatment of gastroenteropancreatic neuroendocrine tumors 8 years ago
Pharma Industry News Santhera’s Raxone rejected in Europe for Duchenne muscular dystrophy 8 years ago